Glomerulonephritis – GN refers to the inflammation as well as damage caused to the filtering units of the kidneys – glomeruli, thereby hindering the removal of waste from the blood. It can be chronic or acute, usually causing hematuria – cola-colored urine, hypertension, edema, and proteinuria – foamy urine. In case you are suffering from this disease, you must visit the best Nephrologist in Patna.
Symptoms of Glomerulonephritis
The symptoms of Glomerulonephritis – Glomerular disease usually include pink/cola-coloured urine, hematuria, foamy urine – proteinuria, fluid retention – edema, and hypertension – high blood pressure. This causes swelling in the hands, feet, and face. Chronic forms of this disease usually show no early signs, whereas others experience a reduction in urination, nausea, and fatigue as well.
Acute and Chronic Symptoms
-
Acute GN – The symptoms usually appear abruptly, like swelling, cola-coloured urine, and high blood pressure after an infection.
-
Chronic GN – The symptoms can develop at a slow pace, sometimes with very few symptoms early on, but it can lead to chronic kidney disease CKD, increased fatigue, and high cholesterol over time.
Chief causes of Glomerulonephritis
Glomerulonephritis – GN and glomerular diseases are generally caused by inflammation as well as scarring of the filtering units of the kidney, stemming from immune system dysfunction, vascular issues, or infections frequently. Chief causes include –
- Infections – Bacterial endocarditis, viral infections like B/C, HIV, Hepatitis, and post-streptococcal glomerulonephritis
- Autoimmune Diseases – Lupus nephritis – SLE, IgA nephropathy
- High Blood Pressure
- Genetic Diseases – Alport Syndrome
- Diabetes
- Vasculitides – Diseases that cause damage to the small vessels
- Toxins/Medications – Exposure to hydrocarbon solvents and certain medications like NSAIDs.
- Membranoproliferative Glomerulonephritis – A disorder in which the antibodies start building up in the kidney.
Diagnosis
The disease Glomerulonephritis is diagnosed via blood tests, urine tests, and a kidney biopsy.
The Treatment Approaches
The treatment of Glomerulonephritis centers on the reduction of inflammation, management of symptoms such as edema and high blood pressure, thereby addressing the underlying cause in order to protect the function of the kidney.
- Blood Pressure Control – ARBs and ACE inhibitors are vital for the management of high blood pressure and the reduction of proteinuria.
- Medications – Corticosteroids are being very commonly used to reduce the inflammation in the kidneys. Immunosuppressants have been used for autoimmune-related causes.
- Dietary Changes – A diet that is generally low in protein, salt, and potassium is recommended for the purpose of reducing the workload on the kidneys.
- Fluid Management – In order to treat edema – swelling, diuretics – water pills are being used.
- Advanced Therapies – for rapidly progressive and severe cases, the treatments can even include dialysis or plasmapheresis. Dialysis refers to the filtration of blood, whereas plasmapheresis refers to the removal of harmful antibodies.
Through the treatment, you can experience a reduction in the inflammation of your kidney, management of your high blood pressure, and diminished protein loss in urine, thereby delaying or preventing chronic kidney disease (CKD or even kidney failure. The benefits you experience after this treatment include filtration of harmful antibodies, reduction in swelling, and potential reversal of damage that was caused through medication such as steroids, ACE inhibitors, and immunosuppressants.
Conclusion
Generally, the underlying cause of Glomerulonephritis is immunologic, in which antigen-antibody reactions or even cell-mediated damage are responsible for destroying the glomerular tissue. The treatment for this disease is highly customised based on the particular cause, type, and severity, thereby making it vital and necessary to monitor kidney function on a regular basis. For effective treatment, you must visit the best kidney specialist in Patna.